Thalidomide induces amenorrhea in patients with lupus disease

Arthritis and Rheumatism

Volumn 41, Issue 12, 1998, Pages 2273-2275

  Ordi, Jose ^a   Cortes, Fina ^a   Martinez, Nuria ^a   Mauri, Montse ^a   De Torres, Ines ^a   Vilardell, Miguel ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; DRUG EFFECT; FEMALE; HUMAN; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; AMENORRHEA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PANNICULITIS, LUPUS ERYTHEMATOSUS; THALIDOMIDE;

EID: 0032441823     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199812)41:12<2273::AID-ART26>3.0.CO;2-6     Document Type: Article

References (13)

1. Kunz W, Keller H, Muckter H. N Phthalyl-glutaminsaure-imid. Arzneimittelforsch 1956;6:426.
2. Gardner-Medwin JM, Powel RJ. Thalidomide: the way forward. Postgrad Med J 1994;70:860-2.
3. Knop J, Bonsmann G, Happle R, Ludolph A, Matz DR, Mifsud EJ, et al. Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol 1983;108:461-6.
4. Stevens RJ, Andujar C, Edwards CJ, Ames PRJ, Barwick AR, Khamashta MA, et al. Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients. Br J Rheumatol 1997;36:353-9.
5. Powell RJ, Garder-Medwin JMM. Guideline for the clinical use and dispensing of thalidomide. Postgrad Med J 1994;70:901-4.
6. Selva A, Ordi J, Rodrigo MJ, Codina R, Castro-Salomó A, Vilardell M. Antiovarian antibodies in systemic lupus erythematosus [abstract]. Br J Rheumatol 1993;32 Suppl 1:12.
7. Khamashta MA, Hughes GRV. Pregnancy in systemic lupus erythematosus. Curr Opin Rheumatol 1996;8:424-9.
8. Wang CL, Wang F, Bosco JJ. Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus. Lupus 1995;4:11-4.
9. Boumpas DT, Austin HA, Vaughan EM, Yarboro CH, Klippel JH, Balow JE. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 1993;119:366-9.
10. Ataya KM, Valerote FA, Ramachi-Ataya AJ. Effects of cyclophosphamide on immature rat ovary. Cancer Res 1989;49:1660-4.
11. Moncayo R, Moncayo HE. A new endocrinological and immunological syndrome in SLE: elevation of human chorionic gonadotropin and of antibodies directed against ovary and endometrium antigens. Lupus 1995;4:39-45.
12. Barnhill RL, Doll NJ, Millikan LE, Hasting RC. Studies on the anti-inflammatory properties of thalidomide: effects on polymorphonuclear leukocyte and monocyte. J Am Acad Dermatol 1984;11:814-9.
13. Powell RJ. New roles for thalidomide. BMJ 1996;313:377-8.